Share-based Payment Arrangement, Expense of Telesis Bio Inc. from 30 Jun 2020 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Telesis Bio Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2020 to 30 Sep 2024.
  • Telesis Bio Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2024 was $566,000, a 51% decline year-over-year.
  • Telesis Bio Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2024 was $2,817,000, a 39% decline year-over-year.
  • Telesis Bio Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3,963,000, a 6.3% increase from 2022.
  • Telesis Bio Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3,727,000, a 243% increase from 2021.
  • Telesis Bio Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1,086,000, a 2426% increase from 2020.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Telesis Bio Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $2,817,000 $566,000 -$590,000 -51% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $3,407,000 $869,000 -$166,000 -16% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $3,573,000 $766,000 -$390,000 -34% 01 Jan 2024 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $3,963,000 $616,000 -$678,000 -52% 01 Oct 2023 31 Dec 2023 10-K 29 Mar 2024 2023 FY
Q3 2023 $4,641,000 $1,156,000 +$241,000 +26% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $4,400,000 $1,035,000 -$83,000 -7.4% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $4,483,000 $1,156,000 +$756,000 +189% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q4 2022 $3,727,000 $1,294,000 +$808,000 +166% 01 Oct 2022 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 $2,919,000 $915,000 +$515,000 +129% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $2,404,000 $1,118,000 +$1,018,000 +1018% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023 2023 Q2
Q1 2022 $1,386,000 $400,000 +$300,000 +300% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q4 2021 $1,086,000 $486,000 01 Oct 2021 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 $400,000 +$300,000 +300% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $100,000 +$90,000 +900% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2
Q1 2021 $100,000 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022 2022 Q1
Q3 2020 $100,000 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $10,000 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2021 Q2

Telesis Bio Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $3,963,000 +$236,000 +6.3% 01 Jan 2023 31 Dec 2023 10-K 29 Mar 2024 2023 FY
2022 $3,727,000 +$2,641,000 +243% 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024 2023 FY
2021 $1,086,000 +$1,043,000 +2426% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2023 2022 FY
2020 $43,000 01 Jan 2020 31 Dec 2020 10-K 23 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.